ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,668.67
0.11%
Dow Jones
43,621.16
0.37%
Gold vs US Dollar
2,918.285
-0.01%
Brent Oil
72.625
0.05%
Bitcoin
88,756.67
0.14%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sonnet BioTherapeutics Holdings Inc (SONN) Share Price

SONN Sonnet BioTherapeutics Holdings Inc

1.50
-0.01 (-0.66%)
26 Feb 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Sonnet BioTherapeutics Holdings Inc NASDAQ:SONN NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.01 -0.66 1.50 1.46 1.69 1.53 1.44 1.51 24,734 01:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 19k -7.44M -2.4259 -0.62 4.63M
 Type  Size  Price  Time  Units 
 9 1 1.50 00:49:26 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SONN News
21/02/202521:05EDGAR2Form 3 - Initial statement of beneficial ownership of securities
19/02/202513:48EDGAR2Form 8-K - Current report
19/02/202513:35GLOBESonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates
18/02/202514:15GLOBESonnet BioTherapeutics Selected for Poster Presentation at the 2025 AACR IO Conference
13/02/202521:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/02/202513:30GLOBESonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business Officer
13/02/202513:09EDGAR2Form 8-K - Current report
Period
Draw mode
Data Downloads for SONN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Sonnet BioTherapeutics Holdings Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads